Onyx (ONXX) volatility flat into Kyprolis FDA panel vote

Onyx Pharmaceutical (Nasdaq: ONXX) overall option implied volatility of 50 is near its 26-week average of 53 according to Track Data, suggesting non-directional price movement as shares are halted into a FDA panel vote for Kyprolis.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• ServiceNow (NOW) call put ratio 3.8 calls to 1 put with a focus on 1200 contracts of July 116 calls
• Morgan Stanley (MS) call put ratio 1.4 calls to 1 put into quarter results
• Circle Internet Group (CRCL) call put ratio 3.1 calls to 1 put with a focus on 6800 contracts of July 70 calls